
239: 2022 in review, CEO indictments, & the year ahead
The Readout Loud
00:00
The Cost Effectiveness of the Cannon Map in Alzheimer's Disease
A nonprofit that does lots of math over the course of sizable PDFs to conclude whether a given treatment is cost effective at different prices. They put out their analysis of the cannon map on Thursday morning as a recording this and came up with a price range of basically between about $8,600 and a little over $20,000 per year for the cannon map. This mystery will likely not be very long as the cannon map is expected to win FDA approval on January 6 or before for that matter.
Transcript
Play full episode